Crossmark

Uncovering leading compounds for alzheimer’s disease treatment: mendelian randomization and virtual screening insights into plasma protein modulation

Published Online: 2025-04-05

Authors

Sun, Xiaohan

Hu, Xiaofei

Wei, Jianming

An, Haoyu https://orcid.org/0009-0007-8385-7964
Funding

Funding for this research was provided by:

Natural Science Foundation of Chongqing Municipality (cstc2021jcyj-msxmX0148)

Beijing Postdoctoral Science Foundation (2023-ZZ-002)

China Postdoctoral Science Foundation (2023M742438)
License Information

Text and Data Mining valid from 2025-04-05

Version of Record valid from 2025-04-05
More Information

Article History

Received: 7 November 2024

Accepted: 10 March 2025

First Online: 5 April 2025

Declarations

:

: All the data used in this study is secondary data and does not contain any data which identifies individual. Therefore, ethical approval is exempted.

: Not applicable.

: None.

Document is current